stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
NIH awards new ...
Contract to provide the entire federal government ...

NIH study finds genetic link ...
Researchers recommend screening for people with ...

Whitescarver steps down as ...
He led the office since 2000.

NIH launches largest clinical ...
Trial will test whether statins can reduce the ...

NIH, South African Medical ...
Two- and five-year awards are first issued under ...

NIH still active in Gulf ...
Three-part research approach focuses on ...

Patient admitted with Ebola ...
The individual is no longer contagious to the ...

NIH funds nine antimicrobial ...
Investigators to develop tools to detect ...

No evidence to change current ...
Findings indicate there is no need to alter ...

Allergy drug inhibits ...
NIH study suggests alternative drug to treat ...

Update on clinical status of ...
Status changes from fair to good condition.

NIAAA recognizes Alcohol ...
Month dedicated to understanding how excessive ...

Study defines brain and ...
NIH-funded findings also point to possible ...

Circulating tumor DNA in ...
Measurement of ctDNA enabled detection of disease ...

Experimental Ebola vaccine ...
Results from US government-sponsored phase 1 ...

Douglas Lowy named Acting ...
His research led to the development of HPV ...

Repurposed experimental ...
NIH-supported research enables clinical trial to ...

NIH forms team of experts to ...
Working Group to host public meetings, seek ...

Update on clinical status of ...
Status changes from serious to fair condition.

Promoting maternal ...
Method teaches mothers how to interpret and ...